Science
Mechanism of Action
Rubia Tinctorum Root Extract operates via its anthraquinone derivatives, including alizarin, purpurin, lucidin, and rubiadin. These compounds are associated with anti-inflammatory, antimicrobic, and antibacterial activities against various pathogens. Additionally, the extract contains active components contributing to antioxidant defense, mitigating oxidative stress. When applied to the skin, it is categorized as a conditioning agent, offering soothing and tonic benefits.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Anthraquinone glycosides found in the extract exhibit increased water solubility compared to their aglycone counterparts. Aglycones such as alizarin and lucidin are extractable into organic solvents like chloroform. Anthraquinone phenols typically dissolve effectively in basic solutions. It is crucial to prevent extraction with hot methanol or ethanol due to potential artifact formation. Strong acids at elevated temperatures (e.g., 2-5% H2SO4 or HCl at 80-100°C) should also be avoided, as they can induce hydrolysis of glycosides.
Conflicts
- Hot methanol or ethanol (during extraction due to artifact formation)
- Strong acids at high temperatures (can lead to hydrolysis of glycosides)
- Potentially sensitive to metal ions like iron (which may impact color)
Safety
Safety Profile
The International Agency for Research on Cancer (IARC) classifies madder root (Rubia tinctorum) as 'not classifiable as to its carcinogenicity to humans (Group 3)', citing inadequate evidence in humans and limited experimental animal data. However, specific components within the extract, particularly lucidin, have been demonstrated to induce liver and kidney tumors in rats and are recognized as genotoxic both in vitro and in vivo. Concerns regarding the mutagenic potential of other anthraquinones, such as rubiadin, have driven efforts to develop non-mutagenic extracts by minimizing these compounds. Acute and subacute dietary toxicity tests in mice indicated no toxic effects at the doses administered. The FDA status remains unknown.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to the documented genotoxic and potential carcinogenic effects of certain anthraquinone derivatives present in Rubia Tinctorum Root Extract, its inclusion in precision skincare formulations is not recommended.
Related
Similar Ingredients
Finding similar ingredients…